Literature DB >> 8491250

Delayed disposition of adriamycin and its active metabolite in haemodialysis patients.

M Goto, H Yoshida, A Honda, T Kumazawa, T Ohbayashi, J Inagaki, N Yamanaka, K Ota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8491250     DOI： 10.1007/BF00271378

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Comparative mammalian metabolism of adriamycin and daunorubicin.

Authors:  H Loveless; E Arena; R L Felsted; N R Bachur
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

2.  Anthracycline antibiotic pharmacology and metabolism.

Authors:  N R Bachur
Journal:  Cancer Treat Rep       Date:  1979-05

Review 3.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

4.  Increased incidence of malignancy in chronic renal failure.

Authors:  G A Sutherland; J Glass; R Gabriel
Journal:  Nephron       Date:  1977       Impact factor: 2.847
  4 in total
  1 in total

1.  Pharmacokinetics of doxorubicin and its active metabolite in patients with normal renal function and in patients on hemodialysis.

Authors:  H Yoshida; M Goto; A Honda; T Nabeshima; T Kumazawa; J Inagaki; N Yamanaka; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.